BiotechTube
Home/Mersana Therapeutics/Timothy B. Lowinger, Ph.D.
TB

Timothy B. Lowinger, Ph.D.

Chief Science and Technology Officer

Mersana Therapeutics

Therapeutic Areas

Oncology

Mersana Therapeutics Pipeline

DrugIndicationPhase
Upifitamab rilsodotin (UpRi)Platinum-Resistant Ovarian CancerPhase 3
XMT-1660Breast Cancer (e.g., HR+/HER2-)Phase 1
XMT-2056Advanced/Recurrent Solid Tumors (HER2+)Phase 1
XMT-1592NSCLC (NaPi2b-expressing)Phase 1

Leadership Team at Mersana Therapeutics

MH
Martin Huber, M.D.
President and Chief Executive Officer
BD
Brian DeSchuytner
Senior Vice President, Chief Financial Officer
AP
Anna Protopapas
Chairperson of the Board of Directors
AY
Arvin Yang, M.D., Ph.D.
Chief Medical Officer
View full Mersana Therapeutics profile